Physician profile

Jay R Mcdougal

Internal Medicine · Belpre, OH

NPI 1134402555

$1,435.94

in general payments reported to CMS, 2019-2025

22 companies · none reported in 2025

See the full distribution for Internal Medicine

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $264.79 2019-2020
Amgen INC. $187.44 2019-2021
Pfizer INC. $176.24 2020-2021
Merck Sharp & Dohme LLC $103.56 2019-2021
Lilly USA, LLC $91.60 2019-2020
Novo Nordisk INC $89.19 2019-2021
Sanofi-Aventis U.S. LLC $77.74 2019-2021
Boehringer Ingelheim Pharmaceuticals, INC. $73.39 2019-2020
Takeda Pharmaceuticals U.S.A., INC. $55.72 2020
Ironshore Pharmaceuticals INC. $42.47 2019
Novartis Pharmaceuticals Corporation $42.14 2019
Janssen Pharmaceuticals, INC $41.60 2019
Glaxosmithkline, LLC. $34.52 2019-2020
Astellas Pharma US INC $26.96 2019
Kowa Pharmaceuticals America, INC. $26.82 2019-2021
Show all 22 companies

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jay R Mcdougal

$1,435.94

in general payments reported 2019-2025

Years
2019-2021
Top company
Astrazeneca Pharmaceuticals LP

https://glasscript.com/doctor/566242/jay-r-mcdougal

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.